Harel Insurance Investments & Financial Services Ltd. Biomarin Pharmaceutical Inc Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 26, 2021	SELL	$72.61 - $90.2 $14,522 - $18,040	-200 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$71.87 - $131.03 $14,374 - $26,206	200 New	200 $15,000
Q4 2018 Jan 29, 2019	SELL	$80.14 - $106.07 $308,218 - $407,945	-3,846 Closed	0 $0
Q3 2018 Oct 29, 2018	SELL	$93.92 - $105.72 $164,735 - $185,432	-1,754 Reduced 31.32%	3,846 $373,000
Q2 2018 Jul 30, 2018	BUY	$76.01 - $99.03 $425,656 - $554,568	5,600 New	5,600 $528,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

Black Rock Inc. New York, NY

22.7M
Shares

$1.52 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.28 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.26 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$926 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$699 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account